IL28B polymorphisms do not predict response to therapy in chronic hepatitis C with HCV genotype 5 | Gut

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via BSG

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Citation Tools

This article has a correction. Please see:

Simulation of macroamylasaemia by salivary-type (`S type') hyperamylasaemia - January 01, 1974

PostScript

Letters

IL28B polymorphisms do not predict response to therapy in chronic hepatitis C with HCV genotype 5

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:: Antaki N, Bibert S, Kebbewar K, et al

IL28B polymorphisms do not predict response to therapy in chronic hepatitis C with HCV genotype 5

Gut 2012;61:1640-1641.